A groundbreaking FDA approval has introduced a new treatment option specifically designed for colorectal cancer patients with ...

Working with a line of colon cancer cells, Korean researchers figured out a way to throw a few genetic switches to cause the ...

Despite advancements in cancer treatment technologies, most therapies share a common goal: eliminating cancer cells. However, ...

Using a computational “digital twin” model, researchers mapped the gene networks controlling cell differentiation. They ...

A Japanese research team has discovered new evidence on how genes function in the large intestine, a move that could shed light on why colorectal cancer often develops on the left side. Colorectal ...

Scientists uncover how disrupted lipid metabolism fuels chronic inflammation in colorectal cancer, offering insights into new therapeutic strategies targeting pro-inflammatory and pro-resolving lipid ...

Larotrectinib sulfate is under clinical development by Bayer and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II drugs for Colorectal Cancer have a 25% phase transition ...